Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol…

Publicações Científicas

Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women. https://pubmed.ncbi.nlm.nih.gov/26172927/ Abstract Combined oral contraceptives (COCs) may increase the risk for cardiovascular disease depending on the ethynyl estradiol (EE) dose and the androgenicity of…

A combined oral contraceptive containing drospirenone…

Publicações Científicas

A combined oral contraceptive containing drospirenone changes neither endothelial function nor hemodynamic parameters in healthy young women: a prospective clinical trial https://pubmed.ncbi.nlm.nih.gov/22465116/ Abstract Background: Combined oral contraceptives (COCs) may lead to a rise in cardiovascular disease risk, possibly associated with changes in blood pressure and endothelial function. Study design: The objective was to evaluate the impact of…

Effects of a contraceptive containing drospirenone and ethinyl estradiol on blood…

Publicações Científicas

Effects of a contraceptive containing drospirenone and ethinyl estradiol on blood pressure and autonomic tone: a prospective controlled clinical trial. https://pubmed.ncbi.nlm.nih.gov/24480113/ Abstract Background: The use of combined oral contraceptives has been associated with an increased risk of adverse cardiovascular events. Whether these drugs alter cardiac autonomic nervous system control is not completely determined. Objective: To evaluate the…